These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6363268

  • 41. Insulin analogues with modifications in the beta-turn of the B-chain.
    Wang SH, Hu SQ, Burke GT, Katsoyannis PG.
    J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
    [Abstract] [Full Text] [Related]

  • 42. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
    Inouye K, Watanabe K, Tochino Y, Kanaya T, Kobayashi M, Shigeta Y.
    Experientia; 1981 Jun; 37(8):811-3. PubMed ID: 7026270
    [Abstract] [Full Text] [Related]

  • 43. The biologic potency and binding affinity of biosynthetic human insulin in isolated rat adipocytes.
    Sonne O, Foley JE, Gliemann J.
    Diabetes Care; 1981 Jun; 4(2):250-1. PubMed ID: 7011738
    [Abstract] [Full Text] [Related]

  • 44. Direct effects of growth hormone on insulin action in rat adipose tissue maintained in vitro.
    Maloff BL, Levine JH, Lockwood DH.
    Endocrinology; 1980 Aug; 107(2):538-44. PubMed ID: 6993190
    [No Abstract] [Full Text] [Related]

  • 45. Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin.
    Sonne O.
    Biochim Biophys Acta; 1987 Jan 19; 927(1):106-11. PubMed ID: 3539208
    [Abstract] [Full Text] [Related]

  • 46. Receptor-isoform-selective insulin analogues give tissue-preferential effects.
    Vienberg SG, Bouman SD, Sørensen H, Stidsen CE, Kjeldsen T, Glendorf T, Sørensen AR, Olsen GS, Andersen B, Nishimura E.
    Biochem J; 2011 Dec 15; 440(3):301-8. PubMed ID: 21851336
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
    Ohta N, Burke GT, Katsoyannis PG.
    J Protein Chem; 1988 Feb 15; 7(1):55-65. PubMed ID: 3076448
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Structural features involved in the biological activity of insulin and the insulin-like growth factors: A27 insulin/BIGF-I.
    Joshi S, Ogawa H, Burke GT, Tseng LY, Rechler MM, Katsoyannis PG.
    Biochem Biophys Res Commun; 1985 Dec 17; 133(2):423-9. PubMed ID: 3002339
    [Abstract] [Full Text] [Related]

  • 57. Insulin-stimulating peptide from tryptic digest of bovine serum albumin.
    Ueno A, Arakaki N, Inoue H, Oribe T, Takeda Y.
    Biochem Biophys Res Commun; 1984 Aug 16; 122(3):1179-85. PubMed ID: 6383374
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM, Piron MA, De Meyts P.
    Diabetes Care; 1981 Aug 16; 4(2):209-14. PubMed ID: 7011729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.